| Dr Colette Simon, MD | |
|
2603 Keiser Blvd Ste 204, Wyomissing, PA 19610-3356 | |
| (484) 628-3939 | |
| (484) 628-3940 |
| Full Name | Dr Colette Simon |
|---|---|
| Gender | Female |
| Speciality | Undersea And Hyperbaric Medicine |
| Experience | 44 Years |
| Location | 2603 Keiser Blvd Ste 204, Wyomissing, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235245036 | NPI | - | NPPES |
| 072790 | Other | PA | MEDICARE PTAN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tower Health Medical Group | 7618889213 | 577 |
News Archive
Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
Ontario-wide - Natural disasters like Hurricane Katrina, the Asian tsunami and other catastrophic events have keenly demonstrated the need for emergency preparedness for government, businesses, households and individuals. When planning for disasters or emergencies, special consideration needs to be taken to include people with disabilities.
A new study by researchers from The Irish Longitudinal Study on Ageing at Trinity College Dublin, Ireland, has shown for the first time that a substantial number of adults over 50 are at risk of deficiency in vitamin B12 and folate (the natural vitamin linked to the dietary supplement, folic acid).
Researchers at Mount Sinai School of Medicine have discovered a novel component of the influenza virus that may be the key to disabling the virus's ability to replicate itself and to developing a universal anti-viral treatment. The findings were published June 1 online in Proceedings of the National Academy of Sciences.
› Verified 7 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
Ontario-wide - Natural disasters like Hurricane Katrina, the Asian tsunami and other catastrophic events have keenly demonstrated the need for emergency preparedness for government, businesses, households and individuals. When planning for disasters or emergencies, special consideration needs to be taken to include people with disabilities.
A new study by researchers from The Irish Longitudinal Study on Ageing at Trinity College Dublin, Ireland, has shown for the first time that a substantial number of adults over 50 are at risk of deficiency in vitamin B12 and folate (the natural vitamin linked to the dietary supplement, folic acid).
Researchers at Mount Sinai School of Medicine have discovered a novel component of the influenza virus that may be the key to disabling the virus's ability to replicate itself and to developing a universal anti-viral treatment. The findings were published June 1 online in Proceedings of the National Academy of Sciences.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Colette Simon, MD 2603 Keiser Blvd Ste 204, Wyomissing, PA 19610-3356 Ph: (484) 628-3939 | Dr Colette Simon, MD 2603 Keiser Blvd Ste 204, Wyomissing, PA 19610-3356 Ph: (484) 628-3939 |
News Archive
Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
Ontario-wide - Natural disasters like Hurricane Katrina, the Asian tsunami and other catastrophic events have keenly demonstrated the need for emergency preparedness for government, businesses, households and individuals. When planning for disasters or emergencies, special consideration needs to be taken to include people with disabilities.
A new study by researchers from The Irish Longitudinal Study on Ageing at Trinity College Dublin, Ireland, has shown for the first time that a substantial number of adults over 50 are at risk of deficiency in vitamin B12 and folate (the natural vitamin linked to the dietary supplement, folic acid).
Researchers at Mount Sinai School of Medicine have discovered a novel component of the influenza virus that may be the key to disabling the virus's ability to replicate itself and to developing a universal anti-viral treatment. The findings were published June 1 online in Proceedings of the National Academy of Sciences.
› Verified 7 days ago